Latest Glioma Stories
VANCOUVER, British Columbia and MENLO PARK, Calif., May 29, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI)
The National Non-profit Organization Continues to Advocate for Brain Cancer and Tumor Research to Ultimately Find a Cure NEW YORK, May 28, 2015 /PRNewswire-USNewswire/ --
VANCOUVER, British Columbia and MENLO PARK, Calif., May 27, 2015 /PRNewswire/ -- DelMar Pharmaceuticals,
NEW YORK, May 27, 2015 /PRNewswire/ -- US-Australian drug discovery and development company, Novogen Limited (ASX: NRT; NASDAQ: NVGN), announced today that it will present at the Brain Tumor
- Lead product candidate, VAL-083 for the treatment of glioblastoma multiforme (GBM), positioned to enter registration-directed Phase II/III clinical trials in 2H 2015 - VANCOUVER, British
Major updates to the Ivy Glioblastoma Atlas Project provide researchers with valuable tools to find cures for aggressive brain cancers SEATTLE, May 14, 2015 /PRNewswire-USNewswire/ -- Robust
Clinical data from a Phase 1 investigator-sponsored study to be presented for MM-398 in high-grade glioma CAMBRIDGE, Mass., May 14, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc.
VANCOUVER, British Columbia and MENLO PARK, Calif., May 7, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc.
Photodynamic therapy with PHOTOFRIN® being studied in range of cancers OAKVILLE, ON, May 7, 2015 /PRNewswire/ - Concordia Healthcare Corp.
Following Meeting with FDA, Company Advances Towards Pivotal Phase 2/3 Trial in Patients with Recurrent High Grade Glioma WASHINGTON, May 4, 2015 /PRNewswire/ --
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.